Aclaris Therapeutics ACRS Market capitalization

Market capitalization at other companies

IncyteINCY

$22.65B+69.5%

Corvus PharmaceuticalsCRVS

$1.23B+467%

Upstream Bio, Inc.UPB

$376.59M-38.5%

Avalo TherapeuticsAVTX

$971.41M+1,712%

Shattuck Labs, Inc.STTK

$662.83M+1,237%

Cullinan Therapeutics, Inc.CGEM

$1.12B+142%

FAQ

What is Aclaris Therapeutics's market capitalization?

Aclaris Therapeutics (ACRS) reported market capitalization of $738.82M in Q2 2026.

How has Aclaris Therapeutics's market capitalization changed year-over-year?

Aclaris Therapeutics's market capitalization increased by 348.9% year-over-year, from $164.59M to $738.82M.

What is the long-term trend for Aclaris Therapeutics's market capitalization?

Over 5 years (2020 to 2025), Aclaris Therapeutics's market capitalization has grown at a -3.8% compound annual growth rate (CAGR), from $396.14M to $326.12M.

What does market capitalization mean?

The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.